Literature DB >> 24845607

Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice.

Daniela C Kroy1, Fabienne Schumacher2, Pierluigi Ramadori2, Maximilian Hatting2, Ina Bergheim3, Nikolaus Gassler4, Mark V Boekschoten5, Michael Müller5, Konrad L Streetz2, Christian Trautwein2.   

Abstract

BACKGROUND & AIMS: Non-alcoholic-fatty-liver disease (NAFLD) is part of the metabolic syndrome. The spectrum of NAFLD includes NASH (non-alcoholic steatohepatitis), which is characterised by progressive inflammation associated with oxidative stress and apoptosis, finally triggering liver cirrhosis and hepatocellular carcinoma. HGF (hepatocyte growth factor)/mesenchymal-epithelial transition factor (c-Met) receptor signalling is known to activate distinct intracellular pathways mediating among others anti-apoptotic properties to hepatocytes. Therefore, the aim was to characterise the role of c-Met during NASH development.
METHODS: Hepatocyte specific c-Met knockout mice (c-MetΔ(hepa)) using the cre-loxP system and wild type controls (c-Met(loxP/loxP)) were fed a methionine-choline deficient (MCD) diet.
RESULTS: MCD feeding triggered massive steatosis, decreased survival and higher transaminases in c-MetΔ(hepa) livers compared to c-Met(loxP/loxP). Gene array analysis demonstrated that genes involved in fatty acid metabolism were strongly upregulated in c-MetΔ(hepa) livers correlating with higher amounts of hepatic free fatty acids. Consequently, c-MetΔ(hepa) mice showed significantly more TUNEL positive cells and more superoxide anion production than c-Met(loxPloxP) animals. Additionally, c-MetΔ(hepa) livers showed significantly larger fractions of infiltrating neutrophils, macrophages, and cytotoxic T cells. These changes correlated with an enhanced progression of liver fibrosis as evidenced by higher collagen deposition in c-MetΔ(hepa) livers. As increased apoptosis was a prominent feature in c-MetΔ(hepa) livers, we generated c-Met/Casp8Δ(hepa) double knockout mice. In these animals compared to c-MetΔ(hepa) animals the increase in apoptosis could be reverted.
CONCLUSIONS: c-Met deletion in hepatocytes triggers NASH progression. A prominent mechanism is higher fatty acid accumulation and increased apoptosis, which in part can be reverted by blocking caspase 8.
Copyright © 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HGF; NASH; c-Met

Mesh:

Substances:

Year:  2014        PMID: 24845607     DOI: 10.1016/j.jhep.2014.05.019

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  25 in total

1.  Biological roles of hepatocyte growth factor-Met signaling from genetically modified animals.

Authors:  Takashi Kato
Journal:  Biomed Rep       Date:  2017-10-18

2.  The carvacrol ameliorates acute pancreatitis-induced liver injury via antioxidant response.

Authors:  Murat Bakır; Fatime Geyikoglu; Suat Colak; Hasan Turkez; Tulay Ozhan Bakır; Mirkhalil Hosseinigouzdagani
Journal:  Cytotechnology       Date:  2015-09-08       Impact factor: 2.058

Review 3.  Immunoregulation by lipids during the development of non-alcoholic steatohepatitis.

Authors:  Pierluigi Ramadori; Daniela Kroy; Konrad L Streetz
Journal:  Hepatobiliary Surg Nutr       Date:  2015-02       Impact factor: 7.293

Review 4.  Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis.

Authors:  Robert F Schwabe; Ira Tabas; Utpal B Pajvani
Journal:  Gastroenterology       Date:  2020-02-08       Impact factor: 22.682

5.  Caspases in metabolic disease and their therapeutic potential.

Authors:  Claire H Wilson; Sharad Kumar
Journal:  Cell Death Differ       Date:  2018-05-09       Impact factor: 15.828

Review 6.  Targeting programmed cell death in metabolic dysfunction-associated fatty liver disease (MAFLD): a promising new therapy.

Authors:  Jianan Zhao; Yiyang Hu; Jinghua Peng
Journal:  Cell Mol Biol Lett       Date:  2021-05-07       Impact factor: 5.787

7.  An in vivo transfection system for inducible gene expression and gene silencing in murine hepatocytes.

Authors:  Eric K Hubner; Christian Lechler; Birgit Kohnke-Ertel; Anne-Flore Zmoos; Julien Sage; Roland M Schmid; Ursula Ehmer
Journal:  J Gene Med       Date:  2017-01       Impact factor: 4.152

8.  Anti-inflammatory effect of HGF responses to oral traumatic ulcers using an HGF-Tg mouse model.

Authors:  Xinhong Wang; Liting Yan; Yinghua Tang; Xiaoxi He; Xiaomin Zhao; Weijia Liu; Zhicong Wu; Gang Luo
Journal:  Exp Anim       Date:  2021-11-25

9.  HGF can reduce accumulation of inflammation and regulate glucose homeostasis in T2D mice.

Authors:  Liting Yan; Xiaoxi He; Yinghua Tang; Xiaomin Zhao; Gang Luo; Xinhong Wang
Journal:  J Physiol Biochem       Date:  2021-08-07       Impact factor: 4.158

10.  Hepatocyte Growth Factor Reduces Free Cholesterol-Mediated Lipotoxicity in Primary Hepatocytes by Countering Oxidative Stress.

Authors:  Mayra Domínguez-Pérez; Natalia Nuño-Lámbarri; Denise Clavijo-Cornejo; Armando Luna-López; Verónica Souza; Leticia Bucio; Roxana U Miranda; Linda Muñoz; Luis Enrique Gomez-Quiroz; Salvador Uribe-Carvajal; María Concepción Gutiérrez-Ruiz
Journal:  Oxid Med Cell Longev       Date:  2016-04-10       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.